Keywords: sanofi-synthelabo, net, earnings, increase, having, recently, announced
Sanofi-Synthelabo net earnings increase 54% for 2000
Article | 21 February 2001
Having recently announced a 10.3% increase in 2000 sales to 5.96 billioneuros ($5.59 billion; Marketletter February 5), France's Sanofi-Synthelabo says that net earnings before extraordinary ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
